Literature DB >> 12241842

New drugs for breast cancer.

Ian E Smith1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12241842     DOI: 10.1016/S0140-6736(02)09903-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Unknown primary carcinoma, diagnosed as inflammatory breast cancer,and successfully treated with trastuzumab and vinorelbine.

Authors:  Hirofumi Asakura; Hitoshi Takashima; Masahiro Mitani; Reiji Haba; Reiko Seo; Koiku Yokoe; Yoshihiro Toyama; Motoomi Ohkawa
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

2.  SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model.

Authors:  Lesley J Murray; Tinya J Abrams; Kelly R Long; Theresa J Ngai; Lisa M Olson; Weiru Hong; Paul K Keast; Jacqueline A Brassard; Anne Marie O'Farrell; Julie M Cherrington; Nancy K Pryer
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.

Authors:  Michael L Gatza; Hsiu-Ni Kung; Kimberly L Blackwell; Mark W Dewhirst; Jeffrey R Marks; Jen-Tsan Chi
Journal:  Breast Cancer Res       Date:  2011-06-07       Impact factor: 6.466

4.  Survival from breast cancer in England and Wales up to 2001.

Authors:  A Leary; I E Smith
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.